Recently, studies using a mediation analysis approach showed that fasting insulin plays a major role in explaining the adiposity–postmenopausal breast cancer association—attributing 58%–65.8% of the association to insulin pathways.6, 16, 17. This evidence concerns the gene INS and breast carcinoma.